Ind-Swift Laboratories Ltd. (INDSWFTLAB): Ind-Swift Laboratories Share Price rises 12.36% as stock gains today
- August 26, 2026
- Posted by: Harsh Piplani
- Category: News
SUMMARY: Ind-Swift Laboratories Share Price rose to Rs 364.55 today, up 12.36%, with market capitalisation at Rs 2,845.82 crore.
Ind-Swift Laboratories Share Price drew attention in today’s Indian stock market after the stock rose 12.36% to Rs 364.55 from a previous close of Rs 324.45. The move added Rs 40.10 in value and placed the company’s market capitalisation at Rs 2,845.82 crore. The session opened at Rs 324.45, touched a low of Rs 324.45 and a high of Rs 372.45, which makes the day’s price action relevant for anyone following Ind-Swift Laboratories Share Price Today, Ind-Swift Laboratories Stock News and broader Stocks in News coverage.
The verified data confirms the price rise, but it does not establish a company-specific catalyst. In that context, the focus shifts to the numbers that can be checked directly: valuation, profitability, sector comparison and the peer set in Pharmaceuticals & Drugs. Univest tracks such moves as part of its stock analysis flow, helping readers compare a share price rise with the company’s financial and sector backdrop without relying on assumptions.
Ind-Swift Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 364.55 |
| Previous Close | Rs 324.45 |
| Today's Move | Rs 40.1 (+12.36%) |
| Open | Rs 324.45 |
| High | Rs 372.45 |
| Low | Rs 324.45 |
| Turnover | Rs 5.65 crore |
| Market Capitalisation | Rs 2,845.82 crore |
| Market Cap Category | Small Cap |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) rose to Rs 364.55 from the previous close of Rs 324.45, a move of Rs 40.1 or 12.36%. The stock opened at Rs 324.45, reached a high of Rs 372.45, recorded a low of Rs 324.45.
Ind-Swift Laboratories Share Price moved from Rs 324.45 to Rs 364.55, a gain of Rs 40.10 or 12.36% in one session. The stock opened at Rs 324.45, matched the day’s low at the same level and went on to touch Rs 372.45 before ending at Rs 364.55. Turnover for the day stood at Rs 5.65 crore. This is the factual price action behind the move in Ind-Swift Laboratories Share Price Today, and it explains why the stock is featuring among Top Gainers Today and Stocks Rising Today.
For readers tracking Ind-Swift Laboratories Share News, the main takeaway is simple: the share price rose sharply on the day, but the supplied data alone does not identify the trigger. Univest therefore treats the event as a verified price rise first, then places it alongside fundamentals and sector benchmarks so the move can be read in context.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,845.82 crore |
| P/E Ratio | 49.22x |
| P/B Ratio | 1.89x |
| ROE | 24.68% |
| ROCE | 24.24% |
| EPS | Rs 6.59 |
| Book Value Per Share | Rs 171.98 |
| Dividend Yield | 0% |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) fundamental metrics show P/E 49.22x, P/B 1.89x, ROE 24.68%, ROCE 24.24%. These figures provide context only and are not a buy or sell signal.
Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 2845.82 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.22x, P/B at 1.89x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 24.68% and ROCE of 24.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 6.59, book value per share of Rs 171.98, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.52x, median ROE of 11.82%, median ROCE of 13.88%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 49.22x |
| Benchmark Median P/E | 30.52x |
| Benchmark Average P/E | 46.79x |
| Benchmark P/E Range | 2.94x to 717.81x |
| Company P/B Ratio | 1.89x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 24.68% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 24.24% |
| Benchmark Median ROCE | 13.88% |
| Company Market Capitalisation | Rs 2,845.82 crore |
| Benchmark Median Market Cap | Rs 613.53 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 49.22x, which is above the benchmark median of 30.52x, a difference of +61.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROE of 24.68%, which is above the benchmark median of 11.82%, a difference of +108.8%. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROCE of 24.24%, which is above the benchmark median of 13.88%, a difference of +74.64%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,58,248.99 | 38.03 | 5.32 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,25,648.29 | 78.78 | 13.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,891.11 | 85.81 | 20.85 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,15,926.93 | 34.03 | 3.26 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,825.17 | 24.98 | 4.18 | 19.69 | 21.39 |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 49.22x compared with the displayed peer median of 38.03x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 24.68% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 24.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a market capitalisation of Rs 2,845.82 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Ind-Swift Laboratories
- Ind-Swift Laboratories Share Price rose 12.36% today to Rs 364.55, with a gain of Rs 40.10.
- The day’s range was Rs 324.45 to Rs 372.45, and the stock closed above the previous close of Rs 324.45.
- Market capitalisation stands at Rs 2,845.82 crore, which places the company above the sector median market cap.
- P/E is 49.22, P/B is 1.89, ROE is 24.68% and ROCE is 24.24%, giving a clear valuation and profitability snapshot.
- In the supplied peer set, ROE and ROCE compare favourably with several larger healthcare peers.
About Ind-Swift Laboratories
Ind-Swift Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For Ind-Swift Laboratories Share Price, the most useful company-level context today is the relationship between valuation and returns rather than any unsupported narrative about the day’s move.
The supplied data identifies the business through its market position and financial profile, but not through segment-wise revenue mix or product detail. As a result, the most reliable description is that it is a pharma-focused listed company whose stock analysis today centres on the verified price rise, the company’s Rs 2,845.82 crore market cap and its profitability ratios. Univest uses this kind of company overview to keep Ind-Swift Laboratories Stock News grounded in facts.
Track Ind-Swift Laboratories Share Price on Univest
Use Ind-Swift Laboratories Ltd. (INDSWFTLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Ind-Swift Laboratories Share Price rising today?
Ans. The supplied data confirms a 12.36% rise in Ind-Swift Laboratories Share Price to Rs 364.55, but it does not establish a company-specific catalyst. The move is verified, while the reason remains unconfirmed.
What is Ind-Swift Laboratories Share Price today?
Ans. Ind-Swift Laboratories Share Price today is Rs 364.55, compared with the previous close of Rs 324.45. The stock gained Rs 40.10 during the session and finished well above its opening level.
How much did Ind-Swift Laboratories stock gain today?
Ans. Ind-Swift Laboratories stock gained 12.36% today, equivalent to Rs 40.10. The day’s high was Rs 372.45, while the low and open were both Rs 324.45. The previous close was Rs 324.45.
What is the market capitalisation of Ind-Swift Laboratories?
Ans. Ind-Swift Laboratories has a market capitalisation of Rs 2,845.82 crore. That places it above the sector median market cap in the supplied benchmark set, though still below the industry average.
How does Ind-Swift Laboratories look on valuation?
Ans. Ind-Swift Laboratories has a P/E ratio of 49.22 and a P/B ratio of 1.89. The P/E is above the sector median and average, while the P/B is below both benchmark readings.
What do the profitability ratios show for Ind-Swift Laboratories?
Ans. ROE stands at 24.68% and ROCE at 24.24% for Ind-Swift Laboratories. Both are above the supplied sector median, which gives useful context for the current Ind-Swift Laboratories Share Price move.
What is Ind-Swift Laboratories EPS and book value?
Ans. Ind-Swift Laboratories EPS is Rs 6.59 and book value is Rs 171.98. EPS shows earnings per share, while book value indicates the accounting net worth behind each share at the current price.
Does Ind-Swift Laboratories pay a dividend?
Ans. The supplied dividend yield is 0, so no dividend yield is shown in the data used for this article. That makes the valuation and profitability metrics more central to Ind-Swift Laboratories Share Price analysis.
